Charles Schwab Investment Management Inc Adaptive Biotechnologies Corp Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 916,743 shares of ADPT stock, worth $5.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

916,743

Previous 906,481 1.13%

Holding current value

$5.86 Million

Previous $3.28 Million 43.04%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$3.37 - $5.12 $34,582 - $52,541	10,262 Added 1.13%	916,743 $4.69 Million
Q2 2024 Aug 12, 2024	BUY	$2.34 - $3.96 $85,875 - $145,328	36,699 Added 4.22%	906,481 $3.28 Million
Q1 2024 May 08, 2024	BUY	$2.88 - $4.8 $327,888 - $546,480	113,850 Added 15.06%	869,782 $2.79 Million
Q4 2023 Feb 06, 2024	SELL	$3.46 - $5.33 $356,847 - $549,709	-103,135 Reduced 12.01%	755,932 $3.7 Million
Q3 2023 Nov 08, 2023	BUY	$5.07 - $8.44 $107,367 - $178,733	21,177 Added 2.53%	859,067 $4.68 Million
Q2 2023 Aug 09, 2023	BUY	$6.19 - $8.78 $90,194 - $127,933	14,571 Added 1.77%	837,890 $5.62 Million
Q1 2023 May 11, 2023	SELL	$7.8 - $10.11 $8,424 - $10,918	-1,080 Reduced 0.13%	823,319 $7.27 Million
Q4 2022 Feb 13, 2023	BUY	$6.26 - $9.34 $163,085 - $243,325	26,052 Added 3.26%	824,399 $6.3 Million
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $1.92 Million - $3.74 Million	-295,271 Reduced 27.0%	798,347 $5.69 Million
Q2 2022 Aug 15, 2022	BUY	$6.4 - $14.73 $1.5 Million - $3.44 Million	233,850 Added 27.2%	1,093,618 $8.85 Million
Q1 2022 May 13, 2022	BUY	$10.12 - $28.9 $193,261 - $551,903	19,097 Added 2.27%	859,768 $11.9 Million
Q4 2021 Feb 11, 2022	BUY	$25.17 - $36.85 $479,513 - $702,029	19,051 Added 2.32%	840,671 $23.6 Million
Q3 2021 Nov 16, 2021	BUY	$30.02 - $39.87 $5.88 Million - $7.8 Million	195,751 Added 31.28%	821,620 $27.9 Million
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $726,947 - $1.01 Million	22,562 Added 3.74%	625,869 $25.6 Million
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $1.93 Million - $3.51 Million	51,881 Added 9.41%	603,307 $24.3 Million
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $475,980 - $692,345	10,575 Added 1.96%	551,426 $32.6 Million
Q3 2020 Nov 13, 2020	BUY	$35.79 - $48.81 $13.7 Million - $18.7 Million	382,289 Added 241.1%	540,851 $26.3 Million
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $304,539 - $590,526	12,206 Added 8.34%	158,562 $7.67 Million
Q1 2020 May 15, 2020	BUY	$16.96 - $34.16 $923,641 - $1.86 Million	54,460 Added 59.26%	146,356 $4.07 Million
Q4 2019 Feb 07, 2020	BUY	$24.56 - $32.8 $44,085 - $58,875	1,795 Added 1.99%	91,896 $2.75 Million
Q3 2019 Nov 08, 2019	BUY	$30.31 - $53.51 $2.73 Million - $4.82 Million	90,101 New	90,101 $2.79 Million

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $913M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Adaptive Biotechnologies Corp Transaction History